An experimental therapy for a rare blood cancer was rejected by the FDA though internal reviewers had recommended it be cleared ...
Eli Lilly's experimental weight-loss pill, orforglipron, caused more side effects and treatment discontinuations than Novo ...
Popular weight-loss drugs, including Ozempic, Wegovy, Trulicity and Mounjaro, produced by independent pharmacy labs, sickened ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results